FDA reform stalling in Senate as August recess approaches.
This article was originally published in The Tan Sheet
Executive Summary
FDA REFORM BILL UNLIKELY TO HIT SENATE FLOOR BEFORE AUGUST RECESS despite being on Senate Majority Leader Lott's (R-Miss.) list of legislative priorities for the month of July. Lott is understood to have canceled plans to bring the bill to the floor, however, because of a failure in the Senate to reach a final agreement on Sen. Kassebaum's (R-Kan.) S 1477. The Senate Majority Leader's office indicates that the floor calendar for the week of July 29 is filled by work on appropriations legislation.